Median consumer price ratio of selected generic medicines
Situation and trends
In some low- and middle-income countries where patients have to pay for medicines in the public sector, prices of selected lowest priced generics can be more than twice international reference prices. For example, in Congo, Philippines and Moldova public sector patient prices were over 400% more than international reference prices. In the private sector, the price of generics ranged from 32% more than international reference prices in Iran to 2700% more in El Salvador. Originator brands are even more costly. Treatments for non-communicable diseases in particular are simply beyond reach in many countries.